ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lucet Strengthens Leadership Team with Appointment of Brian Doheny as Chief Operating Officer

Former Humana Exec Joins Seasoned Team of Healthcare Leaders at Company Redefining Behavioral Health Access and Outcomes

Lucet, a leading provider of behavioral health solutions and services to commercial health plans, government agencies, and other sponsors of care, today announced the appointment of Brian Doheny as the company’s Chief Operating Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230602005208/en/

(Photo: Business Wire)

(Photo: Business Wire)

Mr. Doheny joins Lucet with nearly three decades of healthcare experience accrued across a variety of settings, including senior leadership positions at Humana, UofL Health, CommonSpirit Health, and Ascension. In his new role, Mr. Doheny will focus on building out Lucet’s network of high-quality therapists, behavioral health specialists, and treatment facilities through partnerships and strategic ventures. Additionally, he will provide administrative oversight, while directing Lucet’s member engagement and clinical operations functions.

“I have spent the majority of my career working closely with administrators, clinicians and care teams, as well as patients and community organizations to reduce or remove friction in the delivery system,” observed Doheny. “At a time when consensus can be difficult to achieve, there’s general agreement that the industry can do a better job meeting the needs of those with mental or behavioral health issues. Through its relationships with large national health plans, its technology platform and proprietary Behavioral Health Index (BHI®), and frontline team of experts, Lucet is well-positioned to effect change at-scale.”

Before stepping into his current role, Mr. Doheny distinguished himself at Humana where he served as the Vice President of Medicare Trend and Innovation and shepherded the national expansion of value-based programs. Earlier in his tenure, he led Humana Pharmacy’s retail pharmacy business. Mr. Doheny has also maintained operational oversight and responsibility inside of leading national and regional health systems. He spent three years as the Chief Operating Officer of Jewish Hospital, a 442-bed tertiary care medical center, and four years as the President and CEO of UofL Health-Medical Center South.

“We are thrilled that Brian has chosen to join the Lucet team,” said President and CEO Shana Hoffman. “He brings with him a wealth of knowledge, including that gleaned through strategic transformation initiatives centered on value-based care delivery. Brian will be an invaluable resource and guide as we continue working collaboratively with our clients and partners to correct the systemic imbalance between provider supply and patient demand.”

Mr. Doheny holds an MHA from Washington University in St. Louis, a BA in government and politics from the University of Maryland and is a Fellow of the American College of Healthcare Executives (FACHE).

About Lucet

Lucet's unique combination of people and technology is proven to optimize access to behavioral health care providers and increase a health plan's ability to connect members to quality care. With the industry's largest network of care navigators and technology powered by more than 6 million assessments and more than 20 years of data, Lucet is the only solution proven to successfully identify and connect people across the entire acuity spectrum with the right care in less than 5 days on average, and often as little as 1 day. Lucet is headquartered in Overland Park, Kansas. For more information, follow Lucet on LinkedIn (www.linkedin.com/company/lucethealth) or visit www.LucetHealth.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.